Search Results - "Plazas, J"

Short-term outcomes of chemoradiotherapy and local excision versus total mesorectal excision in T2-T3ab,N0,M0 rectal cancer: a multicentre randomised, controlled, phase III trial (the TAU-TEM study) by Serra-Aracil, X., Pericay, C., Badia-Closa, J., Golda, T., Biondo, S., Hernández, P., Targarona, E., Borda-Arrizabalaga, N., Reina, A., Delgado, S., Vallribera, F., Caro, A., Gallego-Plazas, J., Pascual, M., Álvarez-Laso, C., Guadalajara-Labajo, H.G., Mora-Lopez, L.

“…The standard treatment of T2-T3ab,N0,M0 rectal cancers is total mesorectal excision (TME) due to the high recurrence rates recorded with local excision…”
Get full text

Role of circulating tumor cells as prognostic marker in resected stage III colorectal cancer by Sotelo, M.J., Sastre, J., Maestro, M.L., Veganzones, S., Viéitez, J.M., Alonso, V., Grávalos, C., Escudero, P., Vera, R., Aranda, E., García-Alfonso, P., Gallego-Plazas, J., Lopez, C., Pericay, C., Arrivi, A., Vicente, P., Ballesteros, P., Elez, E., López-Ladrón, A., Díaz-Rubio, E.

“…This is the first study that seeks to establish the prognostic value of circulating tumor cell (CTC) (determined by CellSearch system) in patients with stage…”
Get full text

Pharmacogenetic predictors of severe peripheral neuropathy in colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: a GEMCAD group study by Custodio, A., Moreno-Rubio, J., Aparicio, J., Gallego-Plazas, J., Yaya, R., Maurel, J., Higuera, O., Burgos, E., Ramos, D., Calatrava, A., Andrada, E., López, R., Moreno, V., Madero, R., Cejas, P., Feliu, J.

“…Oxaliplatin-based chemotherapy (CT), widely used as adjuvant therapy for stage III and selected high-risk stage II colon cancer (CC) patients, is often…”
Get full text

Thermal effusivity measurement of conventional and organic coffee oils via photopyroelectric technique by Bedoya, A., Gordillo-Delgado, F., Cruz-Santillana, Y.E., Plazas, J., Marin, E.

“…In this work, oil samples extracted from organic and conventional coffee beans were studied. A fatty acids profile analysis was done using gas chromatography…”
Get full text

Sex and gender disparities in patients with advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry by Plazas, J. Gallego, Arias-Martinez, A., Lecumberri, A., Martínez de Castro, E., Custodio, A., Cano, J.M., Hernandez, R., Montes, A.F., Macias, I., Pieras-Lopez, A., Diez, M., Visa, L., Tocino, R.V., Lago, N. Martínez, Limón, M.L., Gil, M., Pimentel, P., Mangas, M., Granja, M., Carnicero, A.M., Pérez, C. Hernández, Gonzalez, L.G., Jimenez-Fonseca, P., Carmona-Bayonas, A.

“…Recommendations for research articles include the use of the term sex when reporting biological factors and gender for identities or psychosocial or cultural…”
Get full text

Clinical impact of circulating tumor RAS and BRAF mutation dynamics in metastatic colorectal cancer patients treated with first-line chemotherapy plus anti-EGFR therapy: Combined analysis of two prospective clinical trials by Montagut, C, Alonso, V, Escudero, P, Fernández-Martos, C, Salud Salvia, A, Méndez, M, Gallego Plazas, J, Rodriguez, J R, Martín-Richard, M, Fernández-Plana, J, Aparicio, J, Feliu Batlle, J, García de Albéniz, X, Rojo, F, Fernández, V, Claes, B, Maertens, G G, Sablon, E, Jacobs, B A W, Maurel, J

Get full text

Prospective biomarker study in advanced RAS wild-type colorectal cancer: POSIBA trial by García Albéniz, X, Alonso, V, Escudero, P, Méndez, M, Gallego Plazas, J, Rodriguez, J R, Salud Salvia, A, Fernández-Plana, J, Manzano Alemany, H, Zanui, M, Falcó, E, Feliu Batlle, J, Gil-Raga, M, Fernández-Martos, C, Bohn Sarmiento, U, Alonso López, M C, Calderero Aragón, V, Rojo, F, Cuatrecasas, M, Maurel, J

Get full text

Development and internal validation of a predictive nomogram of progression-free survival in well-differentiated stage IV gastroenteropancreatic neuroendocrine tumours treated with somatostatin analogues: GETNE-TRASGU study by Garcia-Carbonero, R., Alonso, V., Capdevila, J., Sanchez Canovas, M., Alonso, T., Benavent, M., Custodio, A., Crespo Herrero, G., Lopez, C., Hernando, J., Riesco Martinez, M.C., Escudero, P., Gallego Plazas, J., Marazuela, M., Diaz, J.A., Llanos-Munoz, M., La Casta, A., Percovich, J.C., Jimenez-Fonseca, P., Carmona-Bayonas, A.

Get full text

Is it time to change follow-up recommendations in colorectal cancer? by Asensio Martínez, E., Gómez González, L., Morales Giménez, R., Pelegrín Mateo, F. J., Fernández Cruz, M., Gallego Plazas, J.

Get full text

2261 Comparison of four prognostic tools based on clinical features for metastatic gastric cancer by Hernandez, R, Sanchez Lorenzo, L, Manga, M, Mugica, M, Visa, L, Rodriguez Palomo, A, Garcia, T, Ramchandani, A, Custodio, A, Longo, F, Azkarate, A, Cerda, P, Limon, M.L, Serrano, R, Alvarez Manceñido, F.J, Vicente, M.A, Gallego Plazas, J, Garrido, M, Jimenez Fonseca, P, Carmona Bayonas, A

Get full text

2033 Stage III colorectal cancer (CRC) in Spain: A retrospective analysis from 35 centres by Sotelo, L, Sastre, J, García-Paredes, B, Cabezas-Camarero, S, Vieitez, J.M, Alonso, V, Grávalos, C, Escudero, P, Vera, R, Aranda, E, García-Alfonso, P, Gallego-Plazas, J, Lopez, C, Pericay, C, Arrivi, A, Vicente, P, Ballesteros, P, Elez, E, Lopez-Ladron, A, Diaz-Rubio, E

Get full text

123 FATAL ENTEROCCAL ENDOCARDITIS COMPLICATING A CANDIDA PARAPSILOSIS ENDOCARDITIS FAILING TO CASPOFUNGIN PLUS FLUCONAZOL by Merino, E, Sergio, R, Boix, V, Portilla, J, Almazán, F, Plazas, J

Get full text

122 ALCALIGENES XYLOSOXIDANS MITRAL NATIVE VALVE ENDOCARDITIS SECONDARY TO CATHETER-RELATED BACTERAEMIA ONE YEAR BEFORE by Merino, E, Reus, S, Boix, V, Portilla, J, Perdiguero, M, Plazas, J, Torrús, D

Get full text

Prevalence of actinic keratosis among dermatology outpatients in Spain by Ferrándiz, C, Plazas, M J, Sabaté, M, Palomino, R

“…Actinic keratoses (AKs) are common skin lesions associated with an increased risk of developing squamous cell carcinoma. Few studies in Europe have focused on…”
Get full text

Norfloxacin decreases bacterial adherence of quinolone‐resistant strains of Escherichia coli isolated from patients with cirrhosis by Gascón, I., Pascual, S., Plazas, J., Sánchez, J., Francés, R., Más, P., Zapater, P., Pérez‐Mateo, M., Such, J.

“…Summary Background:  Long‐term administration of norfloxacin is recommended for secondary prophylaxis of spontaneous bacterial peritonitis in cirrhosis, but it…”
Get full text

P-30 First-line (1L) treatment patterns in advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma (GC/GEJC/EAC): Data from the Spanish AGAMENON-SEOM registry by Jiménez-Fonseca, P., Carmona-Bayonas, A., Gallego Plazas, J., Custodio, A., Visa, L., Martínez de Castro, E., Gómez González, L., Moreno Gutierrez, M., Polanco Sanchez, C., Xiao, H.

Get full text

383P An exosome-based liquid biopsy assay for predicting therapeutic outcomes in patients with metastatic colorectal cancer treated with anti-EGFR therapy: Results from prospective, first-line, PULSE and POSIBA trials by Goel, A., Xu, C., Roy, S., Esposito, F.M., Helena, O., Alonso, V., Yubero Esteban, A., Carlos, F-M., Salud Salvia, M.A., Gallego Plazas, J., Rodriguez Monwbray, J.R., Marta, M.M-R., Fernandez, J., Manzano, H., Aparicio, J., Feliu, J., Maurel, J.

Get full text

134MO Updated efficacy and safety results from phase III GLOW study evaluating zolbetuximab + CAPOX as first-line (1L) treatment for patients with claudin-18 isoform 2-positive (CLDN18.2+), HER2−, locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma by Lordick, F., Shah, M.A., Shitara, K., Ajani, J.A., Bang, Y-J., Enzinger, P.C., Ilson, D.H., van Cutsem, E., Gallego Plazas, J., Huang, J., Shen, L., Oh, S.C., Sunpaweravong, P., Soo, H.H.F., Türk, H.M., Park, J.W., Moran, D., Bhattacharya, P., Cao, Y.J., Xu, R-H.

Get full text

Oral Alitretinoin in the Treatment of Severe Refractory Chronic Hand Eczema in the Spanish National Health System: Description and Analysis of Current Clinical Practice by Urrutia, S, Roustan, G, Plazas, M J, Armengol, S, Paz, S, Lizan, L

“…BACKGROUND AND OBJECTIVEHand eczema affects nearly 10% of the population. The condition becomes severe and chronic in 5% to 7% of cases and is refractory to…”
Get full text

LBA81 Updated efficacy and safety results from phase III GLOW study evaluating zolbetuximab + CAPOX as first-line (1L) treatment for patients with claudin-18 isoform 2-positive (CLDN18.2+), HER2−, locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma by Lordick, F., Shah, M.A., Shitara, K., Ajani, J.A., Bang, Y-J., Enzinger, P.C., Ilson, D.H., Van Cutsem, E., Gallego Plazas, J., Huang, J., Shen, L., Oh, S.C., Sunpaweravong, P., Soo, H.H.F., Türk, H.M., Park, J.W., Moran, D., Bhattacharya, P., Cao, Y.J., Xu, R-H.

Get full text